Detalhe da pesquisa
1.
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.
Cell
; 140(5): 652-65, 2010 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20211135
2.
Disruption of Nurse-like Cell Differentiation as a Therapeutic Strategy for Chronic Lymphocytic Leukemia.
J Immunol
; 209(6): 1212-1223, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35995507
3.
Inhibition of BET Proteins Regulates Fcγ Receptor Function and Reduces Inflammation in Rheumatoid Arthritis.
Int J Mol Sci
; 24(8)2023 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37108786
4.
Activation of the Intracellular Pattern Recognition Receptor NOD2 Promotes Acute Myeloid Leukemia (AML) Cell Apoptosis and Provides a Survival Advantage in an Animal Model of AML.
J Immunol
; 204(7): 1988-1997, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32094205
5.
CD31 Acts as a Checkpoint Molecule and Is Modulated by FcγR-Mediated Signaling in Monocytes.
J Immunol
; 203(12): 3216-3224, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732534
6.
Anti-leukemic effects of all-trans retinoic acid in combination with Daratumumab in acute myeloid leukemia.
Int Immunol
; 30(8): 375-383, 2018 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29868798
7.
Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells.
J Biol Chem
; 291(49): 25656-25666, 2016 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27780867
8.
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia.
Blood
; 125(17): 2689-92, 2015 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25716206
9.
Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.
PLoS Genet
; 9(3): e1003311, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23505378
10.
Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human disease.
Blood
; 122(23): 3778-83, 2013 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24085765
11.
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.
Blood
; 122(11): 1923-34, 2013 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23926298
12.
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias.
Blood
; 122(17): 3034-44, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23970380
13.
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
Blood
; 121(1): 159-69, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23100311
14.
miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eµ-miR-155 transgenic mouse model.
Proc Natl Acad Sci U S A
; 109(49): 20047-52, 2012 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23169640
15.
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response.
Proc Natl Acad Sci U S A
; 109(31): E2110-6, 2012 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-22753494
16.
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia.
Blood
; 120(9): 1765-73, 2012 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22677130
17.
Regulation of acute graft-versus-host disease by microRNA-155.
Blood
; 119(20): 4786-97, 2012 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-22408260
18.
Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia.
Blood
; 119(25): 6025-31, 2012 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22566605
19.
Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia.
JCI Insight
; 9(8)2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38646934
20.
The PP2A inhibitor SET regulates natural killer cell IFN-gamma production.
J Exp Med
; 204(10): 2397-405, 2007 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17875674